{"id":10149,"date":"2026-06-11T01:56:17","date_gmt":"2026-06-10T22:56:17","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10149"},"modified":"2026-06-11T01:56:17","modified_gmt":"2026-06-10T22:56:17","slug":"acc-aha-2026","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/acc-aha-2026\/","title":{"rendered":"ACC\/AHA 2026"},"content":{"rendered":"<p><span>ACC\/AHA 2026<\/span><\/p>\n<p><span>First-Ever Guideline for Cardiovascular-Kidney-<\/span><wbr \/><span>Metabolic (CKM) Syndrome<\/span><\/p>\n<p><span>A practical unified prevention framework linking obesity , kidney, and cardiovascular disease.<\/span><\/p>\n<p><span>* ACC\/AHA released the first guideline dedicated to CKM Syndrome, integrating cardiovascular, kidney, metabolic, and obesity care into a single framework.<\/span><br \/>\n<span>* The guideline replaces the 2013 obesity guideline and recognizes obesity as a central driver of multiorgan disease progression.<\/span><br \/>\n<span>* Introduces a new 4-stage CKM classification from overweight\/prediabetes (Stage 1) to established cardiovascular disease (Stage 4).<\/span><\/p>\n<p><span>CKM Stages (ACC\/AHA 2026)<\/span><\/p>\n<p><span>* Stage 1: Overweight\/obesity or prediabetes.<\/span><br \/>\n<span>* Stage 2: Presence of \u22651 metabolic risk factor (HTN, diabetes, dyslipidemia), CKD, or both<\/span><br \/>\n<span>* Stage 3: Subclinical CVD or very high cardiovascular risk.<\/span><br \/>\n<span>* Stage 4: Established CVD (CAD, HF, Stroke, PAD, AF).<\/span><\/p>\n<p><span>* For the first time, GLP-1 receptor agonists are recommended for selected high-risk patients to reduce cardiovascular events.<\/span><br \/>\n<span>* Supports use of GLP-1 RA and SGLT2 inhibitors in patients with type 2 diabetes and elevated cardiovascular risk.<\/span><br \/>\n<span>* Strong emphasis on multidisciplinary care models involving cardiology, nephrology, endocrinology, obesity medicine, and primary care.<\/span><\/p>\n<p><span>Take-Home Message<\/span><\/p>\n<p><span>The new ACC\/AHA guideline shifts the focus from treating isolated risk factors to managing cardiovascular, kidney, and metabolic disease as one interconnected syndrome, with obesity recognized as a key driver throughout the disease continuum.<\/span><\/p>\n<p><span>Source: Medscape Medical News, June 9, 2026 (ACC\/AHA CKM Guideline; Circulation &amp; JACC).<\/span><\/p>\n<p><a href=\"https:\/\/www.medscape.com\/cardiology?utm_source=chatgpt.com\" target=\"_blank\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.medscape.com\/cardiology?utm_source%3Dchatgpt.com&amp;source=gmail&amp;ust=1781218559162000&amp;usg=AOvVaw0R-mny_WIWYrVasmEfyHNb\" rel=\"noopener\">https:\/\/www.medscape.com\/<wbr \/>cardiology?utm_source=chatgpt.<wbr \/>com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ACC\/AHA 2026 First-Ever Guideline for Cardiovascular-Kidney-Metabolic (CKM) Syndrome A practical unified prevention framework linking obesity , kidney, and cardiovascular disease. * ACC\/AHA released the first guideline dedicated to CKM Syndrome, integrating cardiovascular, kidney, metabolic, and obesity care into a single framework. * The guideline replaces the 2013 obesity guideline and recognizes obesity as a central [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10149","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10149"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10149\/revisions"}],"predecessor-version":[{"id":10150,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10149\/revisions\/10150"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}